Vasculitis occurring after intravenous anistreplase.
Burrows
N
N
Jones
R R
RR
D016255:Anistreplase / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008875:Middle Aged; D014657:Vasculitis / Q000139:chemically induced*
D016255:Anistreplase